ScoreWhy is CellaVision AB ?
1
High Management Efficiency with a high ROE of 19.18%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 15.75
3
Poor long term growth as Operating profit has grown by an annual rate 12.46% of over the last 5 years
4
Flat results in Jun 25
- INTEREST(HY) At SEK 9.37 MM has Grown at 93.59%
5
With ROE of 18.37%, it has a very expensive valuation with a 5.22 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -26.54%, its profits have risen by 4.2% ; the PEG ratio of the company is 6.7
6
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
7
Below par performance in long term as well as near term
- Along with generating -26.54% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to CellaVision AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is CellaVision AB for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
CellaVision AB
-26.54%
10.05
43.15%
OMX Stockholm 30
8.01%
0.44
18.11%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.83%
EBIT Growth (5y)
12.46%
EBIT to Interest (avg)
15.75
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.87
Tax Ratio
20.41%
Dividend Payout Ratio
42.37%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
26.30%
ROE (avg)
19.18%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
5.22
EV to EBIT
21.16
EV to EBITDA
17.85
EV to Capital Employed
5.98
EV to Sales
5.55
PEG Ratio
6.74
Dividend Yield
0.01%
ROCE (Latest)
28.26%
ROE (Latest)
18.37%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at -15.2 %
INVENTORY TURNOVER RATIO(HY)
Highest at 2%
RAW MATERIAL COST(Y)
Fallen by -2.14% (YoY
CASH AND EQV(HY)
Highest at SEK 337.6 MM
-4What is not working for the Company
INTEREST(HY)
At SEK 9.37 MM has Grown at 93.59%
Here's what is working for CellaVision AB
Debt-Equity Ratio
Lowest at -15.2 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 2% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Cash and Eqv
Highest at SEK 337.6 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -2.14% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for CellaVision AB
Interest
At SEK 9.37 MM has Grown at 93.59%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
